SOURCE: The Bedford Report

The Bedford Report

April 16, 2010 09:30 ET

Complimentary Analyst Research on Sirius XM Radio, Inc. (NASDAQ: SIRI), Sprint Nextel Corp. (NYSE: S), Boston Scientific Corp. (NYSE: BSX), MetLife, Inc. (NYSE: MET) and Many More Available at

Note to Editors: The Following Is an Investment Opinion Being Issued by The Bedford Report

TORONTO--(Marketwire - April 16, 2010) - The Bedford Report is pleased to announce that its latest Market Update analyzing recent news and events on Sirius XM Radio, Inc. (NASDAQ: SIRI), Sprint Nextel Corp. (NYSE: S), Boston Scientific Corp. (NYSE: BSX) and MetLife, Inc. (NYSE: MET) has been released.

In this issue of The Bedford Report we predict whether or not shares of Sirius will finally manage to remain above the $1 hurdle. We also explain how Sprint plans to differentiate itself from its peers and address the news that Boston Scientific has resumed distribution of two of its heart defibrillator devices. Furthermore, after learning that MetLife will pay $13.5 million to settle charges it made improper payments to an insurance broker in San Diego, we examine the damages to MetLife's reputation. There is much more analysis regarding these companies and many more available at

Our updated analyst reports on Sirius, Sprint, Boston Scientific and MetLife include:

-- An unbiased view and rating of the company
-- Recent key developments
-- Solid analyst summary -- who's saying what and why?
-- In-depth industry analysis and outlook
-- Major upcoming events to watch out for

Take the few minutes to register with us at and get access to numerous company reports and industry newsletters and stay abreast of market highlights so you can make the best investment decisions at the right time. Like you, we realize that timing is everything and so we only put out updates and analysis when the markets are ripe for immediate action. has not been compensated by any of the above mentioned companies. We act as an independent research portal and are aware that all investment entails inherent risks.

Please view the full disclaimer:

Contact Information